# Enspire DBS Therapy

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/enspire-dbs-therapy

- Industry: Healthcare
- Headquarters: Cleveland, US
- Website: www.enspiredbs.com
- Total disclosed funding: $28M
- Latest round: Series B (Jan 13, 2026)
- Investors on record: 3

## About

Established in 2012 and based in Ohio, US, Enspire DBS Therapy, Inc. operates as a developer of deep brain stimulation therapy solutions for stroke patients to recover motor functions. In January 2026, Enspire DBS Therapy, Inc. raised USD 10.3 million in series B funding led by Genesys Capital Management, with participation from  Cleveland Clinic Ventures and JobsOhio.

The company offers Deep Brain Stimulation (DBS) therapy in conjunction with rehabilitation to help stroke recovery patients regain arm function and improve their quality of life. The firm's DBS therapy works by re-establishing neurological input during stroke rehabilitation, stimulating natural cerebral pathways within the brain. Enspire DBS's approach enables deep stimulation to broadly influence brain functions, promoting excitability of the cortex and plasticity around the stroke area. As of August 2023, Enspire DBS is conducting a clinical trial to assess the safety and effectiveness of DBS combined with physical therapy (DBS + Rehab) for patients experiencing significant impairment after stroke.

The company will use the January 2026 funding to support the further development of its DBS-Enabled stroke rehabilitation services.

## Funding rounds

- Series B, Jan 13, 2026, $10M — Genesys Capital Management, JobsOhio, Cleveland Clinic Ventures
- Series B, Aug 1, 2023, $18M — JobsOhio, Cleveland Clinic Ventures

## Investors

- JobsOhio (https://capitalatlas.ai/funds/jobsohio) — Series B
- Cleveland Clinic Ventures (https://capitalatlas.ai/funds/cleveland-clinic-ventures) — Series B
- Genesys Capital Management (https://capitalatlas.ai/funds/genesys-capital-management) — Series B